We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sagentia Selected by PathoGenetix to Develop Commercial-Scale, Rapid Microbial Detection System

News   Jan 11, 2012

 
Sagentia Selected by PathoGenetix to Develop Commercial-Scale, Rapid Microbial Detection System
 
 
 

RELATED ARTICLES

Novel Technology Makes Biopsies Less Invasive and More Informative

News

A team of NUS researchers has developed a novel technology that could sensitively and accurately detect and classify cancer cells, as well as determine the disease aggressiveness from the least invasive biopsies.

READ MORE

Researchers to Create Quick, Low-Cost Cancer Diagnostic

News

Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.

READ MORE

Lab-on-a-Chip Aids Search for Drugs to Prevent Blood Clots

News

A tiny lab the size of a postage stamp could be the next "big thing" in the search for safer anti-clotting drugs to prevent heart attacks and strokes.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE